ABT vs TASK
Abbott Laboratories (ABT) versus Taskus Inc (TASK) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Taskus Inc (TASK) is a information technology services company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported TASK revenue for 2024-12-31 was $995.0M. Net income was $45.9M. Revenue was up 7.6% from 2023-12-31 to 2024-12-31. TASK currently screens at market cap $492.7M and trailing P/E 4.8.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. TASK currently screens at market cap $492.7M and trailing P/E 4.8.
Not investment advice. Open the ABT and TASK stock pages for the full models.
Not investment advice.